Livzon Pharmaceutical Group Financial Overview
Livzon Pharmaceutical Group's market cap is currently $4.09B. The company's EPS TTM is $0.07360652000000001; its P/E ratio is 15.68; and it has a dividend yield of 3.44%. Livzon Pharmaceutical Group is scheduled to report earnings on October 23, 2025, and the estimated EPS forecast is $0.06. See an overview of income statement, balance sheet, and cash flow financials.
